Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ortega-Loayza AG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-17 z 17
    Tytuł:
    Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs
    Autorzy:
    Becker SL
    Velasco R
    Ortega-Loayza AG
    Pokaż więcej
    Temat:
    pyoderma gangrenosum
    recalcitrant
    refractory
    resistant
    biologics
    Dermatology
    RL1-803
    Źródło:
    Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 2143-2152 (2023)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/recalcitrant-pyoderma-gangrenosum-clinical-burden-and-unmet-needs-peer-reviewed-fulltext-article-CCID; https://doaj.org/toc/1178-7015
    Dostęp URL:
    https://doaj.org/article/c870095fd0914b0182ff40d5864e7b7d  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Arsenicism by Chronic Exposure to Mine Tailings in Peru: An Analysis of 17 Cases with Lesions on Skin and/or Annexes
    Autorzy:
    Ramos W
    Ortega-Loayza AG
    Díaz J
    De La Cruz-Vargas JA
    Tello M
    Ronceros G
    Loayza M
    Gutierrez EL
    Pokaż więcej
    Temat:
    arsenicism
    mine tailings
    peru.
    Dermatology
    RL1-803
    Źródło:
    Clinical, Cosmetic and Investigational Dermatology, Vol Volume 15, Pp 2407-2414 (2022)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/arsenicism-by-chronic-exposure-to-mine-tailings-in-peru-an-analysis-of-peer-reviewed-fulltext-article-CCID; https://doaj.org/toc/1178-7015
    Dostęp URL:
    https://doaj.org/article/35966ed8a430402eab913221db048e92  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Targeted interleukin-12 inhibition in peristomal pyoderma gangrenosum.
    Autorzy:
    Vague M; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
    Baghoomian W; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
    Liu Y; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
    Pokaż więcej
    Źródło:
    Dermatologic therapy [Dermatol Ther] 2022 Sep; Vol. 35 (9), pp. e15725. Date of Electronic Publication: 2022 Aug 02.
    Typ publikacji:
    Letter
    MeSH Terms:
    Pyoderma Gangrenosum*/drug therapy
    Pyoderma Gangrenosum*/etiology
    Humans ; Interleukin-12 ; Wound Healing
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
    Autorzy:
    Agarwal P; Department of Dermatology, SMS Medical College and Hospital, Jaipur 302004, Rajasthan, India.
    Lunge SB; Department of Dermatology, Venereology and Leprosy, Bharati Vidyapeeth (DTU) Medical College and Hospital, Pune 411043, Maharashtra, India.
    Shetty NS; Department of Dermatology, Venereology and Leprosy, Bharati Vidyapeeth (DTU) Medical College and Hospital, Pune 411043, Maharashtra, India.
    Karagaiah P; Department of Dermatology, Bangalore Medical College and Research Institute, Bangalore 560002, Karnataka, India.
    Daveluy S; Department of Dermatology, Wayne State University, Detroit, MI 48202, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR 97239, USA.
    Tzellos T; Department of Dermatology, NLSH University Hospital, 8092 Bodø, Norway.; European Hidradenitis Suppurativa Foundation e.V., 06847 Dessau, Germany.
    Szepietowski JC; European Hidradenitis Suppurativa Foundation e.V., 06847 Dessau, Germany.; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
    Zouboulis CC; European Hidradenitis Suppurativa Foundation e.V., 06847 Dessau, Germany.; Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, 06847 Dessau, Germany.
    Grabbe S; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Goldust M; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Pokaż więcej
    Źródło:
    Journal of clinical medicine [J Clin Med] 2022 Jun 30; Vol. 11 (13). Date of Electronic Publication: 2022 Jun 30.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes.
    Autorzy:
    Westerdahl JS; School of Medicine, University of Utah, Salt Lake City, UT, USA.
    Nusbaum KB; College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
    Chung CG; Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
    Kaffenberger BH; Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
    Pokaż więcej
    Źródło:
    The Journal of dermatological treatment [J Dermatolog Treat] 2022 Jun; Vol. 33 (4), pp. 2386-2390. Date of Electronic Publication: 2021 Jun 14.
    Typ publikacji:
    Letter
    MeSH Terms:
    Dermatologic Agents*/therapeutic use
    Pyoderma Gangrenosum*/drug therapy
    Adjuvants, Immunologic ; Humans ; Ustekinumab/therapeutic use
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Pyoderma gangrenosum study pilot registry: The first step to a better understanding.
    Autorzy:
    Orfaly VE; School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
    Reese AM; School of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
    Friedman M; Department of Rheumatology, Oregon Health & Science University, Portland, Oregon, USA.
    Latour E; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.
    Pokaż więcej
    Źródło:
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society [Wound Repair Regen] 2022 May; Vol. 30 (3), pp. 334-337. Date of Electronic Publication: 2022 Apr 01.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Pyoderma Gangrenosum*/diagnosis
    Pyoderma Gangrenosum*/drug therapy
    Humans ; Pilot Projects ; Prospective Studies ; Registries ; Wound Healing
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Surgical Treatment in Hidradenitis Suppurativa.
    Autorzy:
    Shukla R; Department of Dermatology, All India Institute of Medical Sciences Gorakhpur (AIIMS), Gorakhpur 273008, India.
    Karagaiah P; Department of Dermatology, Bangalore Medical College and Research Institute, Bangalore 560002, India.
    Patil A; Department of Pharmacology, Dr. DY Patil Medical College, Navi Mumbai 400706, India.
    Farnbach K; Department of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health & Science University, Portland, OR 97239, USA.
    Tzellos T; Department of Dermatology, NLSH University Hospital, 8092 Bodø, Norway.; European Hidradenitis Suppurativa Foundation e.V., 06847 Dessau, Germany.
    Szepietowski JC; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
    Giulini M; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Schepler H; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Grabbe S; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Goldust M; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Pokaż więcej
    Źródło:
    Journal of clinical medicine [J Clin Med] 2022 Apr 21; Vol. 11 (9). Date of Electronic Publication: 2022 Apr 21.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Efficacy and Toxicity of Classical Immunosuppressants, Retinoids and Biologics in Hidradenitis Suppurativa.
    Autorzy:
    Das K; Department of Dermatology Venereology and Leprosy, Silchar Medical College, Silchar 788014, India.
    Daveluy S; Department of Dermatology, Wayne State University, Detroit, MI 48202, USA.
    Kroumpouzos G; Department of Dermatology, Alpert Medical School of Brown University, Providence, RI 02903, USA.; Department of Dermatology, Medical School of Jundiaí, São Paulo 13202-550, Brazil.; GK Dermatology, P.C, Weymouth, MA 02190, USA.
    Agarwal K; Department of Dermatology, CNMC, Kolkata 700014, India.
    Podder I; Department of Dermatology, Venereology and Leprosy, College of Medicine and Sagore Dutta Hospital, Kolkata 700058, India.
    Farnbach K; Department of Dermatology, Oregon Health and Science University, Portland, OR 97239, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR 97239, USA.
    Szepietowski JC; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
    Grabbe S; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Goldust M; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
    Pokaż więcej
    Źródło:
    Journal of clinical medicine [J Clin Med] 2022 Jan 27; Vol. 11 (3). Date of Electronic Publication: 2022 Jan 27.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Tofacitinib for the treatment of refractory pyoderma gangrenosum.
    Autorzy:
    Orfaly VE; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
    Kovalenko I; Department of Dermatology, Central State Medical Academy, Moscow, Russia.
    Tolkachjov SN; Department of Mohs Micrographic and Reconstructive Surgery, Epiphany Dermatology, Austin, TX, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
    Nunley JR; Department of Dermatology, Virginia Commonwealth University, Richmond, VA, USA.
    Pokaż więcej
    Źródło:
    Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Aug; Vol. 46 (6), pp. 1082-1085. Date of Electronic Publication: 2021 May 29.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Dermatologic Agents/*therapeutic use
    Piperidines/*therapeutic use
    Protein Kinase Inhibitors/*therapeutic use
    Pyoderma Gangrenosum/*drug therapy
    Pyrimidines/*therapeutic use
    Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/complications ; Leg Dermatoses/drug therapy ; Leg Dermatoses/pathology ; Male ; Middle Aged ; Pyoderma Gangrenosum/complications ; Pyoderma Gangrenosum/pathology ; Surgical Stomas/pathology ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Granuloma annulare following initiation of interleukin-17a antagonist.
    Autorzy:
    Gray AR; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
    Davies OMT; Medical College of Wisconsin, Milwaukee, WI, USA.
    White K; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
    Pokaż więcej
    Źródło:
    Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jul; Vol. 46 (5), pp. 924-926. Date of Electronic Publication: 2021 Feb 24.
    Typ publikacji:
    Case Reports; Letter
    MeSH Terms:
    Antibodies, Monoclonal, Humanized/*adverse effects
    Drug Eruptions/*etiology
    Granuloma Annulare/*chemically induced
    Interleukin-17/*antagonists & inhibitors
    Antibodies, Monoclonal, Humanized/therapeutic use ; Female ; Humans ; Middle Aged ; Psoriasis/drug therapy
    Raport
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Treatment of pyoderma gangrenosum: A multicenter survey-based study assessing satisfaction and quality of life.
    Autorzy:
    Hobbs MM; Department of Dermatology, Mayo Clinic, Jacksonville, Florida, USA.
    Byler R; Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA.
    Latour E; Oregon Health & Science University, Biostatistics Shared Resource, Knight Cancer Institute, Portland, Oregon, USA.
    Bonomo L; Division of Dermatology, University of Washington, Seattle, Washington, USA.
    Hennessy K; Department of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, Florida, USA.
    Cruz-Diaz CN; Department of Dermatology, University of California San Francisco, San Francisco, California, USA.
    Shinohara MM; Division of Dermatology, University of Washington, Seattle, Washington, USA.
    Seminario-Vidal L; Department of Dermatology and Cutaneous Surgery, University of South Florida, Tampa, Florida, USA.
    Shinkai K; Department of Dermatology, University of California San Francisco, San Francisco, California, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, Oregon, USA.
    Pokaż więcej
    Źródło:
    Dermatologic therapy [Dermatol Ther] 2021 Mar; Vol. 34 (2), pp. e14736. Date of Electronic Publication: 2021 Jan 12.
    Typ publikacji:
    Journal Article; Multicenter Study
    MeSH Terms:
    Pyoderma Gangrenosum*/diagnosis
    Pyoderma Gangrenosum*/drug therapy
    Quality of Life*
    Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Personal Satisfaction ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum.
    Autorzy:
    Haag CK; Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, OR, USA.
    Ortega-Loayza AG; Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, OR, USA.
    Latour E; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
    Keller JJ; Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, OR, USA.
    Fett NM; Department of Dermatology, Oregon Health & Science University, Center for Health & Healing, Portland, OR, USA.
    Pokaż więcej
    Źródło:
    The Journal of dermatological treatment [J Dermatolog Treat] 2020 Nov; Vol. 31 (7), pp. 723-726. Date of Electronic Publication: 2019 May 06.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Immunoglobulins, Intravenous/*therapeutic use
    Pyoderma Gangrenosum/*drug therapy
    Administration, Intravenous ; Aged ; Drug Resistance ; Drug Therapy, Combination ; Female ; Glucocorticoids/therapeutic use ; Humans ; Male ; Middle Aged ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The utility and challenges of histopathologic evaluation in the diagnosis of nonmalignant skin ulcers.
    Autorzy:
    Hammer P; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    Latour E; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
    Bohnett MC; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    McKenzie F; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    Korcheva VB; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    Mengden S; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    White KP; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    Ortega-Loayza AG; Oregon Health & Science University, Department of Dermatology, Portland, Oregon, USA.
    Pokaż więcej
    Źródło:
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society [Wound Repair Regen] 2020 Mar; Vol. 28 (2), pp. 219-223. Date of Electronic Publication: 2019 Nov 20.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biopsy*
    Autoimmune Diseases/*diagnosis
    Inflammation/*diagnosis
    Skin Diseases, Infectious/*diagnosis
    Skin Diseases, Vascular/*diagnosis
    Skin Ulcer/*diagnosis
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Autoimmune Diseases/pathology ; Female ; Humans ; Inflammation/pathology ; Male ; Middle Aged ; Retrospective Studies ; Skin Diseases, Infectious/pathology ; Skin Diseases, Vascular/pathology ; Skin Ulcer/pathology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Biologic and small-molecule medications in the management of pyoderma gangrenosum.
    Autorzy:
    McKenzie F; a Department of Dermatology , Oregon Health & Science University , Portland , OR , USA.
    Cash D; b School of Medicine , Virginia Commonwealth University , Richmond , VA , USA.
    Gupta A; b School of Medicine , Virginia Commonwealth University , Richmond , VA , USA.
    Cummings LW; b School of Medicine , Virginia Commonwealth University , Richmond , VA , USA.
    Ortega-Loayza AG; a Department of Dermatology , Oregon Health & Science University , Portland , OR , USA.
    Pokaż więcej
    Źródło:
    The Journal of dermatological treatment [J Dermatolog Treat] 2019 May; Vol. 30 (3), pp. 264-276. Date of Electronic Publication: 2018 Sep 07.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Biological Products/*therapeutic use
    Pyoderma Gangrenosum/*drug therapy
    Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: a multidisciplinary approach.
    Autorzy:
    Carter A; Department of Dermatology, New York Medical College, New York, NY, USA.
    Ortega-Loayza AG; Department of Dermatology, Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA, USA.
    Barrett J; Department of Internal Medicine, Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA, USA.
    Nunley J; Department of Dermatology, Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA, USA.
    Pokaż więcej
    Źródło:
    Clinical and experimental dermatology [Clin Exp Dermatol] 2016 Apr; Vol. 41 (3), pp. 275-8. Date of Electronic Publication: 2015 Aug 20.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Anticoagulants/*therapeutic use
    Calciphylaxis/*drug therapy
    Heparin/*therapeutic use
    Skin Diseases, Metabolic/*drug therapy
    Thrombophilia/*drug therapy
    Female ; Humans ; Leg ; Middle Aged ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Endemic pemphigus foliaceus in the Peruvian Amazon.
    Autorzy:
    Ortega-Loayza AG; Department of Dermatology, Virginia Commonwealth University, Richmond, VA, USA. />Ramos W
    Gutierrez EL
    Jimenez G
    Rojas I
    Galarza C
    Pokaż więcej
    Źródło:
    Clinical and experimental dermatology [Clin Exp Dermatol] 2013 Aug; Vol. 38 (6), pp. 594-600. Date of Electronic Publication: 2013 May 21.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Pemphigus/*epidemiology
    Adolescent ; Adult ; Aged ; Autoantibodies/immunology ; Case-Control Studies ; Child ; Desmoglein 1/immunology ; Desmoglein 3/immunology ; Enzyme-Linked Immunosorbent Assay ; Female ; Fluorescent Antibody Technique ; Humans ; Immunoprecipitation ; Male ; Middle Aged ; Pemphigus/immunology ; Peru/epidemiology ; Prevalence ; Seroepidemiologic Studies ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Facial porokeratosis: A series of six patients.
    Autorzy:
    Gutierrez EL; Institute of Clinical Research, National University of San Marcos, Peru.
    Galarza C
    Ramos W
    Tello M
    De Paz PC
    Bobbio L
    Barquinero A
    Ronceros G
    Ortega-Loayza AG
    Pokaż więcej
    Źródło:
    The Australasian journal of dermatology [Australas J Dermatol] 2010 Aug; Vol. 51 (3), pp. 191-4.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Dermatologic Agents/*therapeutic use
    Isotretinoin/*therapeutic use
    Porokeratosis/*drug therapy
    Porokeratosis/*pathology
    Adult ; Face ; Female ; Humans ; Male ; Middle Aged ; Peru ; Salicylic Acid/therapeutic use ; Tretinoin/therapeutic use ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-17 z 17

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies